ELV vs MOH vs HUM Stock Comparison

Elevance Health, Molina Healthcare and Humana Prices as of Nov 13, 2026 Peers: Industry group
ELV Elevance Health, Inc.
$429.67 +0.4% 1M +30.9% 1Y
Market cap
$92.86B
P/E
18.1x
Revenue (TTM)
$201.83B
Div. yield
1.60%
Managed Care Healthcare
8 wins
MOH Molina Healthcare, Inc.
$209.62 +0.3% 1M +51.4% 1Y
Market cap
$10.90B
P/E
–
Revenue (TTM)
$44.13B
Div. yield
–
Managed Care Healthcare
1 win
HUM Humana Inc
$450.46 +5.4% 1M +90.3% 1Y
Market cap
$54.10B
P/E
43.4x
Revenue (TTM)
$154.19B
Div. yield
0.79%
Managed Care Healthcare
3 wins

Head to Head

12 decided of 12

Elevance Health leads on 8 of the 12 questions below (Elevance Health 8, Humana 3, Molina Healthcare 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionELVMOHHUMLeader
Larger companyMarket capitalisation $92.86B $10.90B $54.10B ELV
Cheaper on earningsLower P/E, profitable companies only 18.1x -223.6x 43.4x ELV
Cheaper on forward earningsLower price / next fiscal year consensus EPS 14.3x 41.0x 50.2x ELV
Faster revenue growthRevenue growth, trailing twelve months +3.6% -0.9% +22.0% HUM
More profitableNet margin, trailing twelve months 2.5% -0.1% 0.8% ELV
Better return on capitalReturn on invested capital 8.3% 2.2% 5.5% ELV
Less leveragedLower net debt / EBITDA -0.5x -14.4x -3.9x MOH
Higher dividend yieldTrailing dividend yield 1.60% — 0.79% ELV
Better 1-year returnPrice return, last 12 months +30.9% +51.4% +90.3% HUM
Better 5-year returnAnnualised price return, 5 years -0.3%/yr -7.7%/yr +0.2%/yr HUM
Less volatileAnnualised volatility, 1 year 35.6% 52.5% 47.3% ELV
Higher overall scoreMean of the five percentile scores vs peers 68/100 36/100 55/100 ELV

Percentile Scorecard

ELVMOHHUM

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisELVMOHHUM
Valuation 81 #6 of 27 42 #16 of 27 69 #9 of 27
Growth 36 #17 of 26 4 #25 of 26 44 #15 of 26
Profitability 72 #8 of 26 32 #18 of 26 48 #14 of 26
Financial Health 68 #9 of 26 64 #10 of 26 80 #6 of 26
Shareholder Returns 82 #4 of 18 – 35 #12 of 18
Overall 68 36 55
  • ELV ranked among 27 companies in Healthcare Payers and Distributors
  • MOH ranked among 27 companies in Healthcare Payers and Distributors
  • HUM ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodELVMOHHUMSPY
1 month +0.4%+0.3%+5.4% -2.0%
3 months +7.3%-1.3%+15.6% -2.8%
6 months +9.4%+13.3%+47.6% +2.0%
Year to date +22.6%+20.8%+75.9% +10.6%
1 year +30.9%+51.4%+90.3% +12.2%
3 years -6.9%-42.2%-10.3% +68.1%
3 years, per year -2.4%-16.7%-3.5% +18.9%
5 years -1.7%-33.1%+1.1% +61.4%
5 years, per year -0.3%-7.7%+0.2% +10.1%
10 years +221.4%+341.0%+133.2% +248.5%
10 years, per year +12.4%+16.0%+8.8% +13.3%

Risk

MeasureELVMOHHUMSPY
Volatility, 1Y 35.6%52.5%47.3% 13.6%
Downside volatility, 1Y 38.1%57.9%50.6% 13.9%
Beta vs S&P 500, 1Y 0.29-0.010.52 1.00
Return / volatility, 1Y 0.870.981.91 0.90
Max drawdown, 5Y -51.2%-70.8%-70.9% -25.4%
From 52-week high -3.5%-13.7%0.0% -3.2%
52-week high $445.45$242.88$450.46 $779.14
52-week low $280.74$122.65$163.67 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleELVMOHHUM
P/E now vs peer median 18.1xmedian 25.2x -223.6xmedian 25.2x 43.4xmedian 25.2x
P/S now vs peer median 0.5xmedian 0.4x 0.2xmedian 0.4x 0.4xmedian 0.4x
EV/EBITDA now vs peer median 9.6xmedian 14.5x 18.3xmedian 14.5x 13.3xmedian 14.5x
P/FCF now vs peer median 14.3xmedian 16.5x 45.8xmedian 16.5x 17.2xmedian 16.5x
P/B now vs peer median 2.1xmedian 2.7x 2.6xmedian 2.7x 2.9xmedian 2.7x
PEG now vs peer median -7.75median 1.72 8.22median 1.72 -1.73median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsELVMOHHUM
Revenue $201.83B $44.13B $154.19B
Gross profit $53.35B $5.56B $20.06B
Operating income $7.70B $172.00M $2.38B
Net income $5.13B -$48.00M $1.26B
Free cash flow $6.51B $238.00M $3.14B
EPS (diluted) $23.62 $-0.93 $10.23
Cash & equivalents $10.35B $4.48B $6.94B
Total debt $30.76B $3.77B $12.82B
Shares (diluted) 217.60M 51.50M 121.83M
Enterprise value -$49.61B -$24.10B -$36.68B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricELVMOHHUM
P/E 18.1x -223.6x 43.4x
P/FCF 14.3x 45.8x 17.2x
P/Operating cash flow 12.2x 32.9x 14.5x
P/S 0.5x 0.2x 0.4x
P/B 2.1x 2.6x 2.9x
P/Tangible book 2.7x 2.6x 2.9x
EV/EBITDA 9.6x 18.3x 13.3x
EV/EBIT 11.4x 35.4x 17.6x
EV/Revenue 0.4x 0.1x 0.3x
EV/FCF 13.5x 25.6x 13.3x
EV/Operating cash flow 11.6x 18.4x 11.2x
PEG (3Y EPS CAGR) -7.75 8.22 -1.73

Growth

14 metrics
MetricELVMOHHUM
Revenue growth (1Y) 3.6% -0.9% 22.0%
Revenue CAGR (3Y) 6.2% 9.9% 14.6%
Gross profit growth (1Y) 4.3% -10.2% 6.2%
Gross profit CAGR (3Y) 5.5% 3.3% 3.4%
Operating income growth (1Y) -9.2% -87.0% -19.8%
Operating income CAGR (3Y) -4.2% -49.8% -19.0%
Net income growth (1Y) -7.4% -105.4% -2.9%
Net income CAGR (3Y) -5.2% -27.1% -25.2%
EPS growth (1Y) -4.5% -105.5% -4.3%
EPS CAGR (3Y) -2.3% -27.2% -25.1%
Operating cash flow growth (1Y) 54.6% 171.8% 82.4%
Operating cash flow CAGR (3Y) -7.2% -46.3% -14.6%
Free cash flow growth (1Y) 72.9% 141.5% 102.9%
Free cash flow CAGR (3Y) -7.6% -51.1% -14.3%

Profitability

14 metrics
MetricELVMOHHUM
Gross margin 26.4% 12.6% 13.0%
EBITDA margin 4.6% 0.8% 2.0%
Operating margin 3.8% 0.4% 1.5%
Pretax margin 3.1% -0.1% 1.1%
Net margin 2.5% -0.1% 0.8%
FCF margin 3.2% 0.5% 2.0%
Operating cash flow margin 3.8% 0.8% 2.4%
Return on equity 11.4% -1.2% 6.6%
Return on assets 4.0% -0.3% 2.2%
Return on invested capital 8.3% 2.2% 5.5%
Return on capital employed 9.6% 2.0% 7.2%
Asset turnover 1.6x 2.8x 2.7x
Cash conversion (OCF / net income) 1.5x -6.9x 3.0x
Stock comp / revenue 0.1% 0.2% 0.1%

Financial Health

11 metrics
MetricELVMOHHUM
Debt / assets 24.1% 24.1% 22.4%
Debt / equity 0.7x 0.9x 0.7x
Net debt / EBITDA -0.5x -14.4x -3.9x
Debt / FCF 4.7x 15.8x 4.1x
Liabilities / assets 65.0% 73.5% 67.0%
Equity / assets 35.0% 26.5% 33.0%
Interest coverage 5.3x 0.8x 3.2x
Current ratio 1.5x 1.7x 1.6x
Quick ratio 1.2x 1.6x 1.2x
Cash ratio 0.8x 1.2x 1.0x
Altman Z-score 3.06 4.15 4.75

Shareholder Returns

7 metrics
MetricELVMOHHUM
Dividend yield 1.6% – 0.8%
Net buyback yield 2.2% – 0.3%
Shareholder yield 3.8% – 1.1%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusELVMOHHUM
Forward P/E 14.3xFY2026 41.0xFY2026 50.2xFY2026
EPS, next fiscal year $30.12FY2026 $5.11FY2026 $8.98FY2026
EPS growth, next FY -0.6%FY2026 -53.7%FY2026 -47.6%FY2026
EPS growth, the year after +4.2% +93.0% +95.0%
Revenue, next fiscal year $211.92BFY2026 $41.59BFY2026 $167.02BFY2026
Revenue growth, next FY +7.3%FY2026 -8.5%FY2026 +28.8%FY2026
Revenue growth, the year after +0.0% +20.4% +11.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersELVMOHHUM
Held by institutions 91.8% 100.0% 98.6%
Institutions holding 1,615 600 930
Change in shares held, QoQ +1.7% +1.2% +2.7%
Institutions buying 862 364 560
Institutions selling 542 170 267
Buyers to sellers 1.59 2.14 2.10

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ELVMOHHUM
ELV 1.00 0.46 0.57
MOH 0.46 1.00 0.35
HUM 0.57 0.35 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ELV, MOH and HUM?

Elevance Health (ELV) is the largest by market capitalisation: Elevance Health (ELV) $92.86B, Molina Healthcare (MOH) $10.90B, Humana (HUM) $54.10B.

Which stock is cheaper, ELV, MOH and HUM?

Elevance Health (ELV) trades on the lowest price-to-earnings ratio (Elevance Health (ELV) 18.1x, Molina Healthcare (MOH) -223.6x, Humana (HUM) 43.4x). On next year's consensus earnings, Elevance Health (ELV) is cheapest (Elevance Health (ELV) 14.3x, Molina Healthcare (MOH) 41.0x, Humana (HUM) 50.2x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Humana (HUM) grew revenue fastest over the trailing twelve months: Elevance Health (ELV) +3.6%, Molina Healthcare (MOH) -0.9%, Humana (HUM) +22.0%.

Which company is more profitable?

Elevance Health (ELV) has the highest net margin (Elevance Health (ELV) 2.5%, Molina Healthcare (MOH) -0.1%, Humana (HUM) 0.8%). On return on invested capital, Elevance Health (ELV) leads (Elevance Health (ELV) 8.3%, Molina Healthcare (MOH) 2.2%, Humana (HUM) 5.5%).

Which stock has performed better?

Over the past year Humana (HUM) returned the most: Elevance Health (ELV) +30.9%, Molina Healthcare (MOH) +51.4%, Humana (HUM) +90.3%. Over five years, Humana (HUM) compounded fastest (Elevance Health (ELV) -0.3%/yr, Molina Healthcare (MOH) -7.7%/yr, Humana (HUM) +0.2%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Elevance Health (ELV) has the highest dividend yield: Elevance Health (ELV) 1.60%, Humana (HUM) 0.79%. Molina Healthcare (MOH) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Elevance Health (ELV) has been the steadiest (Elevance Health (ELV) 35.6%, Molina Healthcare (MOH) 52.5%, Humana (HUM) 47.3%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ELV, MOH and HUM?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Elevance Health (ELV) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.